Curcumin Alleviates Endometriosis in Sexually Mature Female Mice by Targeting PKA and Inhibiting De Novo Estrogen Synthesis
article
OA: gold
CC0
AI-generated summary
Curcumin alleviates endometriosis in female mice by directly inhibiting protein kinase A, which suppresses de novo estrogen synthesis and reduces ectopic lesion formation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background: Endometriosis is an estrogen-dependent disorder with limited treatment options. The precise molecular targets of curcumin and its effects on local estrogen synthesis in this disease remain unclear. Methods: We investigated curcumin’s efficacy and mechanism via network pharmacology, in vitro functional assays in ectopic endometrial cells, an allogeneic mouse model, and target validation through molecular docking, thermal shift, and hydrolysis stability assays. Results: Curcumin significantly inhibited ectopic cell malignant phenotypes, reducing migration distance by 55.60 ± 7.32%, 80.34 ± 11.19%, and 82.88 ± 13.67% at 5, 10, and 15 μM, respectively, and decreasing invasive cell numbers by 40.38 ± 7.67%, 58.33 ± 12.70%, and 60.18 ± 9.07%, respectively (all p < 0.05). In a mouse model, curcumin (200 mg/kg/day) reduced lesion number by 38.46% (2.167 ± 0.752 vs. 1.333 ± 0.516, p = 0.0493) and lesion volume by 59.73% (0.0497 ± 0.0173 vs. 0.0200 ± 0.0130 mm3, p = 0.00732). It also suppressed de novo estrogen synthesis and modulated the estrogen receptor α (ERα) and β (ERβ) ratio. Mechanistically, curcumin directly bound to and inhibited protein kinase A (PKA), a key kinase in the cAMP signaling pathway. Conclusions: We first demonstrate that curcumin alleviates endometriosis by targeting PKA to inhibit local estrogen synthesis, identifying PKA as a novel therapeutic target and curcumin as a promising treatment candidate.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- 8 Endometriosis-associated infertility via openalex
- Endometriosis and uterine fibroids and risk of premature mortality: prospective cohort study via openalex
- Endometriosis caused by retrograde menstruation: now demonstrated by DNA evidence via openalex
- Endometriosis: Cell Death and Cell Signaling Machinery via openalex
- Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology via openalex
- Endometriosis: recent advances that could accelerate diagnosis and improve care via openalex
- Estrogen Receptor (ER) β Regulates ERα Expression in Stromal Cells Derived from Ovarian Endometriosis via openalex
- Hormonal therapies for endometriosis-associated pain: inflammatory limitations and pharmacological challenges via openalex
- Impact of Endometriosis on Fatigue and Productivity Impairment in a Cross-Sectional Survey of Canadian Women via openalex
- Single-cell and spatial transcriptomic profiling revealed niche interactions sustaining growth of endometriotic lesions via openalex
- The Main Theories on the Pathogenesis of Endometriosis via openalex
- The Molecular and Cellular Mechanisms of Endometriosis: From Basic Pathophysiology to Clinical Implications via openalex
- The pathogenesis of endometriosis and adenomyosis: insights from single-cell RNA sequencing† via openalex
- Treatment after endometrioma recurrence: a narrative review via openalex
- W4409218026 via openalex
- W7125929845 via openalex
- W2067115104 via openalex
- W4394932311 via openalex
- W2143675738 via openalex
- W4406753403 via openalex
- W4408051548 via openalex
- W4409166509 via openalex
Source provenance
- openalex
- last seen: 2026-09-18T06:00:52.566879+00:00
License: CC0
· commercial use OK